Friday, May 15, 2020

Aarti Drugs Q4

Aarti Drugs Q4 Revenues down 2% at Rs 450 cr vs Rs 459 cr Net profit up 115% at Rs 58.9 cr vs Rs 27.4 cr EBITDA up 27% at Rs 71.5 cr vs Rs 56.3 cr Margins at 15.9% vs 12.2%  

FII and DII Trading activities as on 15 May. 2020

FII and DII Trading activities as on 15 May. 2020 FII F&O (Net) - 279.42 Cr FII INDEX FUTURES - 619.86 Cr FII INDEX OPTIONS + 811.64 Cr FII STOCK FUTURES - 318.79 Cr FII STOCK OPTIONS - 152.41 Cr FII CASH - 2388.04 Cr DII CASH + 1225.53 Cr